miR-15a/16
|
Down-regulated
|
Regulating MM cell proliferation through AKT3, MAPKs and NFκB pathways and by targeting cyclin D1, cyclin D2 and CDC25A
|
[10]
|
miR-15a/16
|
Down-regulated
|
induction of BMSC-mediated drug resistance in MM cells, possibly through IL-6
|
[28,35]
|
miR-21
|
Up-regulated
|
Induction of BMSC-mediated drug resistance in MM cells partially through NFκB pathway and by targeting RhoB
|
[27]
|
miR-199a-5p
|
Down-regulated
|
Regulating bone marrow angiogenesis through targeting HIF-1α in MM cells and modulating interaction with BMSCs and bone marrow endothelial cells
|
[32]
|
miR-135b
|
Up-regulated
|
Up-regulated in MM bone marrow mesenchymal stem cells following interaction with MM cells, impairing osteogenesis by targeting SMAD5
|
[34]
|
miR-199a, -24-3p, 15a-5p, 16-5p |
Down-regulated |
Down-regulated in MM mesenchymal cells, contributing to impaired osteogenesis |
[33] |